E-MTAB-7453
RNA-seq of the human melanoma cell-line A375P treated with the BRAF inhibitor PLX4720 and a DMSO control
The human melanoma cell line A375P was subjected to PLX4720 treatment for 36 hours.
The human melanoma cell line A375P was subjected to PLX4720 treatment for 36 hours.